We have to disregard the current share price because it does not reflect the work being done behind the scenes IMO
I think this post from @MickeyMantle536 put it well
"When you have a big Pharma-based Director like Bob Clark sign on with a package that starts at $1.00 a share and incorporates incentives that contemplate a $10 billion takeover, perhaps it’s time to consider that there’s a lot more going on than we might understand.
Lately I’m trying to ignore the day to day price and just accept the reality that the Directors have demonstrated they know what they’re doing. If we develop a genuine drug there’s going to be a massive pay day for everyone and I think it’s critical that Bob Clark is incentivized to achieve that result."
Good luck @Badvet73
IHL - INCANNEX - Takeover that exceeds a valuation of $10b?, page-4
Add to My Watchlist
What is My Watchlist?